نتایج جستجو برای: smallpox

تعداد نتایج: 2761  

Journal: :American Journal of Public Health 1972

1945
S. C. Seal

PREVENTION OF SMALLPOX BY VACCINATION AND REVACCINATION Sir,?In reference to the paper entitled ' Prevention of Smallpox by Vaccination and Revaccination' published in the May 1945 issue of your esteemed journal I beg to further supplement my observations by offering the following hypothesis regarding the conception of immunity and its fluctuations, conferred by smallpox vaccination and revacci...

2013
D. A. Henderson Petra Klepac

It has been more than 35 years since the last naturally occurring case of smallpox. Sufficient time has passed to allow an objective overview of what were the key factors in the success of the eradication effort and what lessons smallpox can offer to other campaigns. Professor D. A. Henderson headed the international effort to eradicate smallpox. Here, we present a summary of D. A. Henderson's ...

Journal: :Canadian Journal of Infectious Diseases 2003

Journal: :Epidemiology and Infection 1969

2013

Content Background .................................................................................................................................................... 3 First generation smallpox vaccines ............................................................................................................... 3 Second generation vaccines ......................................................

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011
Itay Wiser Nadav Orr Zehava Smetana Ania Spungin-Bialik Ella Mendelson Daniel Cohen

BACKGROUND Successful smallpox vaccination is traditionally defined by clinical response ("take"). Nevertheless, only 60% of subjects in the 2002 Israeli smallpox revaccination campaign developed clinical take. More sensitive immunological markers are needed to document successful revaccination. We compared the level of vaccinia-specific immune markers among subjects who did or did not develop ...

2011
Amanda D. Rice Mathew M. Adams Bernhard Lampert Scott Foster Randall Lanier Alice Robertson George Painter Richard W. Moyer

CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. CMX001 has dramatically increased potency versus CDV against all dsDNA viruses and, in contrast to CDV, is orally available and has shown no evidence of nephrotoxicity in healthy volunteers or severely ill transplant patients to date....

2010
Aysegul Nalca Elizabeth E Zumbrun

Smallpox was eradicated more than 30 years ago, but heightened concerns over bioterrorism have brought smallpox and smallpox vaccination back to the forefront. The previously licensed smallpox vaccine in the United States, Dryvax (Wyeth Laboratories, Inc.), was highly effective, but the supply was insufficient to vaccinate the entire current US population. Additionally, Dryvax had a questionabl...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008
Louisa E Chapman John K Iskander Robert T Chen John Neff Guthrie S Birkhead Gregory Poland Gregory C Gray Jane Siegel Kent Sepkowitz Rose Marie Robertson Clyde Yancy Fernando A Guerra Pierce Gardner John F Modlin Toby Maurer Tim Berger W Dana Flanders Robert Shope

The US Department of Defense requested that the Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board joint Smallpox Vaccine Safety Working Group define the likelihood that smallpox vaccination played a causal role in the fatal illness of an Army reservist. Reported serious adverse events for which there was no a priori reason to discount the existence of a causal asso...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید